Instant access to all of our content. Corporate Subscription | 30 Day Trial
September 30 2009
Thomas Starlinger of Fiebinger Polak Leon & Partner Rechtsanwälte GmbH
Fundamental differences remain between these markets. But is it worth considering using a New York participation agreement in an English deal?
How to avoid fighting banking disputes in foreign
jurisdictions. And whether it is worth the effort
Wary of overly restrictive regulation, the derivatives industry is driving measures to improve the transparency and clearing of OTC instruments. But will its efforts be enough?
Pedro Aguiar de Freitas and Ana Carolina Barretto of Veirano Advogados discuss project finance in the emerging Brazilian energy market
Despite interest in IDRs as a viable fund-raising option, issuers have been reluctant to engage in the actual process of issuing them. The onerous nature of the eligibility norms has made it possible only for large co...
The fallout from minibonds arranged by Lehman Brothers shocked Hong Kong, and brought retail structured products to a halt. But now it's making a tentative return
Investors with distressed debt positions and no security are employing novel tactics to leverage their influence: maintain a large interest, collaborate with other bondholders, and get the press on side
September 20 2009
September 16 2009
Recommendations to increase scrutiny of verification and risk assurance practices on securitisation deals will meet opposition from practitioners, and could lead to big increases in deal costs
September 09 2009
September 08 2009